DOCSLIB.ORG

Pumilio Proteins Regulate Translation in Embryonic Stem Cells and Are Essential for Early Embryonic Development Katherine Elizabeth Uyhazi Yale University

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pumilio Proteins Regulate Translation in Embryonic Stem Cells and Are Essential for Early Embryonic Development Katherine Elizabeth Uyhazi Yale University Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 12-2012 Pumilio Proteins Regulate Translation in Embryonic Stem Cells and are Essential for Early Embryonic Development Katherine Elizabeth Uyhazi Yale University. Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Part of the Medicine and Health Sciences Commons Recommended Citation Uyhazi, Katherine Elizabeth, "Pumilio Proteins Regulate Translation in Embryonic Stem Cells and are Essential for Early Embryonic Development" (2012). Yale Medicine Thesis Digital Library. 2189. http://elischolar.library.yale.edu/ymtdl/2189 This Open Access Dissertation is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. ABSTRACT Pumilio Proteins Regulate Translation in Embryonic Stem Cells and are Essential for Early Embryonic Development Katherine E. Uyhazi 2012 Embryonic stem (ES) cells are defined by their dual abilities to self-renew and to differentiate into any cell type in the body. This vast potential is precisely controlled by spatial and temporal gene regulation at transcriptional, post-transcriptional, and epigenetic levels. Recent studies have revealed several transcription factors that are essential for stem cell self-renewal and pluripotency, but the role of translational control in ES cells is poorly understood. Translational control is a fundamental mechanism of gene regulation during early development, and likely explains the discrepancies between the transcriptome and proteome profiles of stem cells and their differentiated progeny. Pumilio proteins are well-characterized RNA-binding translational repressors that are required for germline stem cell maintenance in Drosophila. However, relatively little is known about the two mammalian Pumilio proteins, Pumilio 1 (Puml) and Pumilio 2 (Pum2). In this dissertation I characterize the mRNA targets, protein partners, and in vitro and in vivo function of Puml and Pum2. Puml - and Pum2-deficient mouse embryonic stem cell (mES) lines and conditional knockout mice were generated as a means to unravel the function of Pumilio proteins in ES cells and during early development. Puml -/- and Pum2 -/- ES cells grow more slowly than wild type ES cells but remain self-renewing and pluripotent. Puml-/- 1 and Pum2 -/- mice are fertile and viable. Puml-/- mice are smaller than their littermates, have a hunched appearance that becomes more prominent with age, frequently develop ulcerative dermatitis, and have disorganized, blunted intestinal villi compared to wild type mice. Puml+/-;Pum2-/- mice are viable, Puml-/-; Pum2 +/- mice are born alive but have no oral intake and die within 24 hours, and Pum 1-/-; Pum2 -/- double knockout animals are embryonic lethal by e8.5. Puml and Pum2 are highly expressed in the cytoplasm of mES cells. RNA Immunoprecipitation-Microarray (RIP-Chip) analysis of mES lysate reveals that Puml binds to 1947 mRNAs and Pum2 binds to 437 mRNAs that comprise almost a complete subset of Puml targets. Transcription factors, genes involved in cell cycle control, and genes involved in embryonic patterning are significantly enriched among the mRNA targets of both Puml and Pum2. Several targets including Cyclin E, Cyclin Bl, and Pum2 are translationally repressed by Pum 1, as indicated by changes in protein level without corresponding changes in mRNA level. In mES cells, Puml is part of a -450 kDa protein complex and Pum2 is part of a -350 kDa complex as shown by size exclusion chromatography. Co-immunoprecipitation and mass spectrometry were used to identify three novel binding partners of Puml: Anaphase-promoting complex subunit 1 (APC1), Regulator of nonsense transcripts 1 (RENT1), and Zinc Finger Protein 198 (ZNF198). Overall, this study reveals an essential function of mammalian Pumilio proteins during early embryogenesis, identifies mRNA targets that are translationally controlled by Puml and Pum2 in mES cells, and suggests novel protein-protein interactions that lend insight into the mechanism of action of Pumilio-mediated translational repression. 2 Pumilio Proteins Regulate Translation in Embryonic Stem Cells and are Essential for Early Embryonic Development A Dissertation Presented to the Faculty of the Graduate School of Yale University In Candidacy for the Degree of Doctor of Philosophy by Katherine Elizabeth Uyhazi Dissertation Director: Haifan Lin December 2012 3 © 2012 by Katherine E. Uyhazi All rights reserved. 4 Table of Contents List of Figures 7 List of Abbreviations 9 Acknowledgements 10 Chapter 1: Introduction 12 Embryonic Stem Cells and Translational Control 12 Pumilio is a Well-Characterized Translational Repressor in Drosophila 16 Pumilio Proteins Bind Directly to RNA 19 Evolutionary and Functional Conservation of Pumilio Proteins 22 Stem Cell Maintenance: An Ancestral Function of Pumilio Proteins 25 Chapter 2: The Function of Pumilio Proteins in Embryonic Stem Cells and Early Embryogenesis 29 Introduction 29 Mouse Embryogenesis 29 Murine Pumilio Proteins 32 Results 35 Puml and Pum2 are cytoplasmic in mouse embryonic stem cells 35 Pum-deficient mES cells grow more slowly but are self-renewing and pluripotent 35 Puml -/- mice are viable but are smaller than their littermates 47 Puml and Pum2 are partially functionally redundant 54 5 Puml -/-; Pum2 -/- mice axe embryonic lethal by e8.5 58 Discussion 65 Chapter 3: mRNA Targets and Protein Partners of Pumilio in mES Cells 71 Introduction 71 mRNA Targets of Pumilio Proteins 71 Protein Partners of Pumilio Proteins 73 Results 77 Puml binds to the mRNAs of 1947 genes in mES cells 77 Puml translationally represses Cyclin Bl, Cyclin El, Cyclin E2, and Pum2 80 Pum2 binds to the mRNAs of 437 genes in mES cells 84 Puml is a component of a 450 kDa complex and Pum2 is a component of a 350 kDa protein complex in mES cells 84 Puml directly binds to APC1, Rentl, and ZNF198 88 mRNA Targets of Puml and Pum2 are present in the co-IP of Rent 1 88 Discussion 91 Chapter 4: Conclusions 98 Chapter 5: Experimental Procedures 104 Appendix A: Puml RIP-Chip Microarray Analysis Ill Appendix B: Pum2 RIP-Chip Microarray Analysis 120 Appendix C: Overlapping mRNA targets of Puml and Pum2 130 Literature Cited 132 6 List of Figures Figure 1: Translational regulation in mouse embryonic stem cells 14 Figure 2: Structure and function of Pumilio proteins 18 Figure 3: Evolutionary conservation of the PUM-HD 23 Figure 4: Pumilio is required for the self-renewing asymmetric divisions of germline stem cells during Drosophila oogenesis 27 Figure 5: Murine embryogenesis 30 Figure 6: Subcellular localization of Puml and Pum2 36 Figure 7: Puml knockdown results in fewer mES cells 38 Figure 8: Derivation of Puml-deficient ES cell lines 39 Figure 9: Puml -/- cells are viable but grow more slowly than Puml+/1 cells 41 Figure 10: Cell doubling time of WT, Puml+/-, and Puml-/- ES cells 42 Figure 11: Cell proliferation is not impaired in Puml-/- ES cells 43 Figure 12: Puml-deficient cells have an increased rate of apoptosis 45 Figure 13: Embryoid body generation and lineage marker expression analysis 46 Figure 14: Generation of Puml knockout mice 48 Figure 15: Puml-/- mice are smaller than Puml+/- and WT littermates 49 Figure 16: Puml-/- mice have smaller organs than Puml+/- and WT littermates 50 Figure 17: Aged Puml-/- mice are smaller, have a prominent hunched appearance, and have an increased incidence of ulcerative dermatitis 52 Figure 18: Puml-/- mice have blunted, disorganized villi in the small intestine 53 Figure 19: Generation of Pum2 knockout mice 55 Figure 20: Pum2 -/- mice weigh the same as Pum2+/- and WT littermates 56 7 Figure 21: Puml -/-; Pum2 +/- ES cells have an increased cell doubling time 57 Figure 22: Puml-/-; Pum2 -/- double knockout mice are not viable at birth 59 Figure 23: Puml -/-; Pum2 -/- embryos are viable at e3.5 60 Figure 24: Puml -/- ;Pum2 -/- double knockout embryos are viable at e8.5 but appear developmentally delayed and have reduced tissue mass 62 Figure 25: Puml-deficient embryos are smaller at e9.5 63 Figure 26: Phenotype of el2.5 embryos 64 Figure 27: Pumilio proteins bind to functionally-related mRNAs in many species 72 Figure 28: Puml RNA Immunoprecipitation-Microarray (RIP-Chip) 78 Figure 29: Gene set enrichment analysis of Puml mRNA targets 79 Figure 30: Puml translationally represses mRNA targets in ES cells 81 Figure 31: The 3'UTR of Puml mRNA targets is sufficient for translational regulation in vitro 82 Figure 32: Pum2 binds to a subset of Puml mRNA targets 85 Figure 33: Puml elutes as part of a 450-660 kDa complex, and Pum2 elutes as part of a 350 kDa complex in mES cells 86 Figure 34: Puml directly binds to APC1, RENT1, and ZNF198 in ES cells 89 Figure 35: mRNA targets of Puml are present in the co-immunoprecipitate ofRENTl 90 Figure 36: A potential model of Pumilio-mediated mRNA repression 96 8 List of Abbreviations 3'UTR 3' Untranslated Region 5'UTR 5'Untranslated Region APCl Anaphase-Promoting Complex Subimit 1 ES cells Embryonic stem cells LIF Leukemia inhibitory factor MEF mouse embryonic fibroblasts mRNA messenger RNA miRNA microRNA Nos Nanos NRE Nanos Response Element PUF PUmilio and FBF Puml Pumilio 1 Pum2 Pumilio 2 Pum-HD Pumilio- Homology Domain RENTl Regulator of Nonsense Transcripts 1 (UPFl) ZNF198 Zinc Finger Nuclease 198 9 Acknowledgements First and foremost, I would like to thank my advisor Dr. Haifan Lin for his constant support and encouragement throughout my graduate training. Experiments didn't always work, but he always had helpful suggestions and advice to steer me in the right direction. His outgoing personality and wonderful sense of humor made the lab a fun place to be, and I hope that even a tiny fraction of his scientific knowledge and clarity of thinking have rubbed off on me over the years.
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Evidence for Differential Alternative Splicing in Blood of Young Boys With
    Stamova et al. Molecular Autism 2013, 4:30 http://www.molecularautism.com/content/4/1/30 RESEARCH Open Access Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders Boryana S Stamova1,2,5*, Yingfang Tian1,2,4, Christine W Nordahl1,3, Mark D Shen1,3, Sally Rogers1,3, David G Amaral1,3 and Frank R Sharp1,2 Abstract Background: Since RNA expression differences have been reported in autism spectrum disorder (ASD) for blood and brain, and differential alternative splicing (DAS) has been reported in ASD brains, we determined if there was DAS in blood mRNA of ASD subjects compared to typically developing (TD) controls, as well as in ASD subgroups related to cerebral volume. Methods: RNA from blood was processed on whole genome exon arrays for 2-4–year-old ASD and TD boys. An ANCOVA with age and batch as covariates was used to predict DAS for ALL ASD (n=30), ASD with normal total cerebral volumes (NTCV), and ASD with large total cerebral volumes (LTCV) compared to TD controls (n=20). Results: A total of 53 genes were predicted to have DAS for ALL ASD versus TD, 169 genes for ASD_NTCV versus TD, 1 gene for ASD_LTCV versus TD, and 27 genes for ASD_LTCV versus ASD_NTCV. These differences were significant at P <0.05 after false discovery rate corrections for multiple comparisons (FDR <5% false positives). A number of the genes predicted to have DAS in ASD are known to regulate DAS (SFPQ, SRPK1, SRSF11, SRSF2IP, FUS, LSM14A). In addition, a number of genes with predicted DAS are involved in pathways implicated in previous ASD studies, such as ROS monocyte/macrophage, Natural Killer Cell, mTOR, and NGF signaling.
    [Show full text]
  • Molecular Signatures in IASLC/ATS/ERS Classified Growth Patterns of Lung Adenocarcinoma
    RESEARCH ARTICLE Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma 1 1 1,2 1¤a Heike ZabeckID *, Hendrik Dienemann , Hans Hoffmann , Joachim Pfannschmidt , Arne Warth2,3, Philipp A. Schnabel3¤b, Thomas Muley2,4, Michael Meister2,4, Holger SuÈ ltmann2,5, Holger FroÈ hlich6, Ruprecht Kuner2,5¤c, Felix Lasitschka3 1 Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany, 2 Translational Lung Research Centre Heidelberg (TLRC-H), German Centre for Lung Research (DZL), a1111111111 Heidelberg, Germany, 3 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany, a1111111111 4 Translational Research Unit (STF), Thoraxklinik, University of Heidelberg, Heidelberg, Germany, 5 Cancer a1111111111 Genome Research (B063), German Cancer Research Center (DKFZ) and German Cancer Consortium a1111111111 (DKTK), Heidelberg, Germany, 6 Institute for Computer Science, c/o Bonn-Aachen International Center for a1111111111 IT, Algorithmic Bioinformatics, University of Bonn, Bonn, Germany ¤a Current address: Department of Thoracic Surgery, Lung Clinic Heckeshorn at HELIOS Hospital Emil von Behring, Berlin, Germany ¤b Current address: Institute of Pathology, Saarland University, Homburg/Saar, Germany ¤c Current address: TRONÐTranslational Oncology at the University Medical Center of Johannes OPEN ACCESS Gutenberg University, Mainz, Germany * [email protected] Citation: Zabeck H, Dienemann H, Hoffmann H, Pfannschmidt J, Warth A, Schnabel PA, et al. (2018) Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma. Abstract PLoS ONE 13(10): e0206132. https://doi.org/ 10.1371/journal.pone.0206132 Editor: Stefania Crispi, Institute for Bioscience and Background Biotechnology Research, ITALY The current classification of human lung adenocarcinoma defines five different histological Received: April 4, 2018 growth patterns within the group of conventional invasive adenocarcinomas.
    [Show full text]
  • A Role for Dazl in Commitment to Gametogenic Fate in Embryonic Germ Cells of C57BL/6 Mice
    A Role for Dazl in Commitment to Gametogenic Fate in Embryonic Germ Cells of C57BL/6 Mice by Yanfeng Lin (Yen-Hong Lim) B.S. Biochemistry and Molecular and Cell Biology University of Wisconsin-Madison, 1998 SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN BIOLOGY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY SEPT 2005 C 2005 Yanfeng Lin. All rights reserved. The author hereby grants to MIT permission to reproduce and distribute publicly paper and electronic copies of this thesis document in whole or in part. Signature of Author __ _ __ Department of Biology August, 2005 V /-' ~J-2 Certified by David C. Page Professor of Biology Howard Hughes Medical Institute Thesis Supervisor Accepted b) Stephen P. Bell Co-chair, Biology Graduate Student Committee 'MACHUS ETT S NS1 I OF TECHNOLOGY ARCHIVES' OCT 0 2005 . ,. -~ I LIBRARIES .i. __ A Role for Dazl in Commitment to Gametogenic Fate in Embryonic Germ Cells of C57BL/6 Mice by Yanfeng Lin (Yen-Hong Lim) Submitted to the Department of Biology on June, 2005 in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biology Abstract Germ cells can be defined as the cells that undergo the terminal differentiating process of meiosis. In mice, as XX germ cells enter meiosis around Embryonic days 13.5-14.5 (E13.5-E14.5), they form meiotic figures and down-regulate pluripotency markers. XY germ cells enter proliferation arrest between E13.5 and E16.5, which is accompanied by a distinct morphological change as well.
    [Show full text]
  • Nuclear PTEN Safeguards Pre-Mrna Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role
    ARTICLE DOI: 10.1038/s41467-018-04760-1 OPEN Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role Shao-Ming Shen1, Yan Ji2, Cheng Zhang1, Shuang-Shu Dong2, Shuo Yang1, Zhong Xiong1, Meng-Kai Ge1, Yun Yu1, Li Xia1, Meng Guo1, Jin-Ke Cheng3, Jun-Ling Liu1,3, Jian-Xiu Yu1,3 & Guo-Qiang Chen1 Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are 1234567890():,; largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers. 1 Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. 2 Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and SJTU-SM, Shanghai 200025, China.
    [Show full text]
  • Dynamic Changes in RNA–Protein Interactions and RNA Secondary Structure in Mammalian Erythropoiesis
    Published Online: 27 July, 2021 | Supp Info: http://doi.org/10.26508/lsa.202000659 Downloaded from life-science-alliance.org on 30 September, 2021 Resource Dynamic changes in RNA–protein interactions and RNA secondary structure in mammalian erythropoiesis Mengge Shan1,2 , Xinjun Ji3, Kevin Janssen5 , Ian M Silverman3 , Jesse Humenik3, Ben A Garcia5, Stephen A Liebhaber3,4, Brian D Gregory1,2 Two features of eukaryotic RNA molecules that regulate their and RNA secondary structure. These techniques generally either post-transcriptional fates are RNA secondary structure and RNA- use chemical probing agents or structure-specific RNases (single- binding protein (RBP) interaction sites. However, a comprehen- stranded RNases (ssRNases) and double-stranded RNases [dsRNa- sive global overview of the dynamic nature of these sequence ses]) to provide site-specific evidence for a region being in single- or features during erythropoiesis has never been obtained. Here, we double-stranded configurations (4, 5). use our ribonuclease-mediated structure and RBP-binding site To date, the known repertoire of RBP–RNA interaction sites has mapping approach to reveal the global landscape of RNA sec- been built on a protein-by-protein basis, with studies identifying ondary structure and RBP–RNA interaction sites and the dynamics the targets of a single protein of interest, often through the use of of these features during this important developmental process. techniques such as crosslinking and immunoprecipitation se- We identify dynamic patterns of RNA secondary structure and RBP quencing (CLIP-seq) (6). In CLIP-seq, samples are irradiated with UV binding throughout the process and determine a set of corre- to induce the cross-linking of proteins to their RNA targets.
    [Show full text]
  • Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte As Tumorigenic Precursor and DMRT1 As Candidate Chromosome 9 Gene
    Research Article Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene Leendert H.J. Looijenga,1 Remko Hersmus,1 Ad J.M. Gillis,1 Rolph Pfundt,4 Hans J. Stoop,1 Ruud J.H.L.M. van Gurp,1 Joris Veltman,1 H. Berna Beverloo,2 Ellen van Drunen,2 Ad Geurts van Kessel,4 Renee Reijo Pera,5 Dominik T. Schneider,6 Brenda Summersgill,7 Janet Shipley,7 Alan McIntyre,7 Peter van der Spek,3 Eric Schoenmakers,4 and J. Wolter Oosterhuis1 1Department of Pathology, Josephine Nefkens Institute; Departments of 2Clinical Genetics and 3Bioinformatics, Erasmus Medical Center/ University Medical Center, Rotterdam, the Netherlands; 4Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands; 5Howard Hughes Medical Institute, Whitehead Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts; 6Clinic of Paediatric Oncology, Haematology and Immunology, Heinrich-Heine University, Du¨sseldorf, Germany; 7Molecular Cytogenetics, Section of Molecular Carcinogenesis, The Institute of Cancer Research, Sutton, Surrey, United Kingdom Abstract histochemistry, DMRT1 (a male-specific transcriptional regulator) was identified as a likely candidate gene for Spermatocytic seminomas are solid tumors found solely in the involvement in the development of spermatocytic seminomas. testis of predominantly elderly individuals. We investigated these tumors using a genome-wide analysis for structural and (Cancer Res 2006; 66(1): 290-302) numerical chromosomal changes through conventional kar- yotyping, spectral karyotyping, and array comparative Introduction genomic hybridization using a 32 K genomic tiling-path Spermatocytic seminomas are benign testicular tumors that resolution BAC platform (confirmed by in situ hybridization).
    [Show full text]
  • The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease
    International Journal of Molecular Sciences Review The Alter Retina: Alternative Splicing of Retinal Genes in Health and Disease Izarbe Aísa-Marín 1,2 , Rocío García-Arroyo 1,3 , Serena Mirra 1,2 and Gemma Marfany 1,2,3,* 1 Departament of Genetics, Microbiology and Statistics, Avda. Diagonal 643, Universitat de Barcelona, 08028 Barcelona, Spain; [email protected] (I.A.-M.); [email protected] (R.G.-A.); [email protected] (S.M.) 2 Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Universitat de Barcelona, 08028 Barcelona, Spain 3 Institute of Biomedicine (IBUB, IBUB-IRSJD), Universitat de Barcelona, 08028 Barcelona, Spain * Correspondence: [email protected] Abstract: Alternative splicing of mRNA is an essential mechanism to regulate and increase the diversity of the transcriptome and proteome. Alternative splicing frequently occurs in a tissue- or time-specific manner, contributing to differential gene expression between cell types during development. Neural tissues present extremely complex splicing programs and display the highest number of alternative splicing events. As an extension of the central nervous system, the retina constitutes an excellent system to illustrate the high diversity of neural transcripts. The retina expresses retinal specific splicing factors and produces a large number of alternative transcripts, including exclusive tissue-specific exons, which require an exquisite regulation. In fact, a current challenge in the genetic diagnosis of inherited retinal diseases stems from the lack of information regarding alternative splicing of retinal genes, as a considerable percentage of mutations alter splicing Citation: Aísa-Marín, I.; or the relative production of alternative transcripts. Modulation of alternative splicing in the retina García-Arroyo, R.; Mirra, S.; Marfany, is also instrumental in the design of novel therapeutic approaches for retinal dystrophies, since it G.
    [Show full text]
  • Mrna Editing, Processing and Quality Control in Caenorhabditis Elegans
    | WORMBOOK mRNA Editing, Processing and Quality Control in Caenorhabditis elegans Joshua A. Arribere,*,1 Hidehito Kuroyanagi,†,1 and Heather A. Hundley‡,1 *Department of MCD Biology, UC Santa Cruz, California 95064, †Laboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan, and ‡Medical Sciences Program, Indiana University School of Medicine-Bloomington, Indiana 47405 ABSTRACT While DNA serves as the blueprint of life, the distinct functions of each cell are determined by the dynamic expression of genes from the static genome. The amount and specific sequences of RNAs expressed in a given cell involves a number of regulated processes including RNA synthesis (transcription), processing, splicing, modification, polyadenylation, stability, translation, and degradation. As errors during mRNA production can create gene products that are deleterious to the organism, quality control mechanisms exist to survey and remove errors in mRNA expression and processing. Here, we will provide an overview of mRNA processing and quality control mechanisms that occur in Caenorhabditis elegans, with a focus on those that occur on protein-coding genes after transcription initiation. In addition, we will describe the genetic and technical approaches that have allowed studies in C. elegans to reveal important mechanistic insight into these processes. KEYWORDS Caenorhabditis elegans; splicing; RNA editing; RNA modification; polyadenylation; quality control; WormBook TABLE OF CONTENTS Abstract 531 RNA Editing and Modification 533 Adenosine-to-inosine RNA editing 533 The C. elegans A-to-I editing machinery 534 RNA editing in space and time 535 ADARs regulate the levels and fates of endogenous dsRNA 537 Are other modifications present in C.
    [Show full text]
  • Disrupted Alternative Splicing for Genes Implicated in Splicing and Ciliogenesis Causes PRPF31 Retinitis Pigmentosa
    ARTICLE DOI: 10.1038/s41467-018-06448-y OPEN Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa Adriana Buskin et al.# Mutations in pre-mRNA processing factors (PRPFs) cause autosomal-dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed genes cause non- 1234567890():,; syndromic retinal disease. Here, we generate transcriptome profiles from RP11 (PRPF31- mutated) patient-derived retinal organoids and retinal pigment epithelium (RPE), as well as Prpf31+/− mouse tissues, which revealed that disrupted alternative splicing occurred for specific splicing programmes. Mis-splicing of genes encoding pre-mRNA splicing proteins was limited to patient-specific retinal cells and Prpf31+/− mouse retinae and RPE. Mis-splicing of genes implicated in ciliogenesis and cellular adhesion was associated with severe RPE defects that include disrupted apical – basal polarity, reduced trans-epithelial resistance and phagocytic capacity, and decreased cilia length and incidence. Disrupted cilia morphology also occurred in patient-derived photoreceptors, associated with progressive degeneration and cellular stress. In situ gene editing of a pathogenic mutation rescued protein expression and key cellular phenotypes in RPE and photoreceptors, providing proof of concept for future therapeutic strategies. Correspondence and requests for materials should be addressed to S.-N.G. (email: [email protected]) or to C.A.J. (email: [email protected]) or to M.L. (email: [email protected]). #A full list of authors and their affliations appears at the end of the paper. NATURE COMMUNICATIONS | (2018) 9:4234 | DOI: 10.1038/s41467-018-06448-y | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06448-y etinitis pigmentosa (RP) is one of the most common c.522_527+10del heterozygous mutation (Supplementary Rinherited forms of retinal blindness with a prevalence of Data 1).
    [Show full text]
  • Intermolecular Interactions of Homologs of Germ Plasm Components in Mammalian Germ Cells Mark S
    Dominican Scholar Collected Faculty and Staff Scholarship Faculty and Staff Scholarship 2007 Intermolecular Interactions of Homologs of Germ Plasm Components in Mammalian Germ Cells Mark S. Fox Center for Reproductive Sciences; Human Embryonic Stem Cell Research Center; Department of Obstetrics, Gynecology and Reproductive Sciences; Institute for Stem Cell and Tissue Biology; Departments of Physiology and Urology; University of California at San Francisco Amander T. Clark Center for Reproductive Sciences; Human Embryonic Stem Cell Research Center; Department of Obstetrics, Gynecology and Reproductive Sciences; Institute for Stem Cell and Tissue Biology; Departments of Physiology and Urology; University of California at San Francisco Mohammed El Majdoubi Center for Reproductive Sciences; Human Embryonic Stem Cell Research Center; Department of Obstetrics, Gynecology and Reproductive Sciences; Institute for Stem Cell and Tissue Biology; Departments of Physiology and Urology; University of California at San Francisco, [email protected] Recommended Citation Fox, Mark S.; Clark, Amander T.; El Majdoubi, Mohammed; Vigne, Jean-Louis; Urano, Jun; Hostetler, Chris E.; Griswold, Michael D.; Weiner, Richard I.; and Reijo Pera, Renee A., "Intermolecular Interactions of Homologs of Germ Plasm Components in Mammalian Germ Cells" (2007). Collected Faculty and Staff Scholarship. 308. https://scholar.dominican.edu/all-faculty/308 DOI http://dx.doi.org/https://doi.org/10.1016/j.ydbio.2006.08.047 This Article is brought to you for free and open access by the Faculty and Staff Scholarship at Dominican Scholar. It has been accepted for inclusion in Collected Faculty and Staff Scholarship by an authorized administrator of Dominican Scholar. For more information, please contact [email protected].
    [Show full text]
  • AAV-Mediated Gene Augmentation Therapy Restores Critical Functions in Mutant Ipsc
    bioRxiv preprint doi: https://doi.org/10.1101/729160; this version posted August 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: AAV-mediated gene augmentation therapy restores critical functions in mutant iPSC- derived PRPF31+/- cells. Short title: Gene therapy for PRPF31-linked retinopathy. Authors: Elizabeth M. Brydon1*, Revital Bronstein1*, Adriana Buskin2, Majlinda Lako2, Eric A. Pierce1, and Rosario Fernandez-Godino1. * These authors contributed equally to this work. Affiliations 1. Ocular Genomics Institute at Mass Eye and Ear-Harvard Medical School. Department of Ophthalmology. 2. Institute of Genetic Medicine, Newcastle University, UK Correspondence should be addressed to Rosario Fernandez-Godino: [email protected] 243 Charles St. Boston, MA 02114 Tel. +1 617-573-6787 Fax. +1 617-573-6901 1 bioRxiv preprint doi: https://doi.org/10.1101/729160; this version posted August 8, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Retinitis pigmentosa (RP) is the most common form of inherited vision loss and is characterized by degeneration of retinal photoreceptor cells and the retinal pigment epithelium (RPE). Mutations in pre- mRNA processing factor 31 (PRPF31) cause dominant RP via haploinsufficiency with incomplete penetrance. There is good evidence that the diverse severity of this disease is a result of differing levels of expression of the wild type allele among patients. Thus, we hypothesize that PRPF31-related RP will be amenable to treatment by adeno-associated virus (AAV)-mediated gene augmentation therapy.
    [Show full text]